<?xml version="1.0" encoding="UTF-8"?>
<ref id="fsn31935-bib-0031">
 <mixed-citation publication-type="journal" id="fsn31935-cit-0031">
  <string-name>
   <surname>Loepfe</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Duss</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zafeiropoulou</surname>, 
   <given-names>K.‐A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Björgvinsdóttir</surname>, 
   <given-names>O.</given-names>
  </string-name>, 
  <string-name>
   <surname>D’Este</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Eglin</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Fortunato</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Klasen</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ferguson</surname>, 
   <given-names>S. J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wuertz‐Kozak</surname>, 
   <given-names>K.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Krupkova</surname>, 
   <given-names>O.</given-names>
  </string-name> (
  <year>2019</year>). 
  <article-title>Electrospray‐based microencapsulation of epigallocatechin 3‐gallate for local delivery into the intervertebral disc</article-title>. 
  <source xml:lang="en">Pharmaceutics</source>, 
  <volume>11</volume>, 
  <fpage>435</fpage>–
  <lpage>442</lpage>. 
  <pub-id pub-id-type="doi">10.3390/pharmaceutics11090435</pub-id>
 </mixed-citation>
</ref>
